Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Peripheral blood film patterns

Haematology and transfusion · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Blasts or abnormal promyelocytes, schistocytes with thrombocytopenia and organ symptoms, intracellular malaria parasites in an unwell traveller, or overwhelming sepsis morphology requires immediate clinical and specialist action. The film should accelerate treatment and definitive sampling, not become a reason to wait for a perfect classification.

Synopsis

Use blood-film morphology to verify automated counts, recognise time-critical haematological patterns and direct confirmatory testing without turning a descriptive cell shape into a final diagnosis.

  • Read the film alongside the full blood count, reticulocytes, clinical question and sampling history. Morphology without the numerical and clinical context is vulnerable to over-interpretation.
  • Start at low power for distribution, rouleaux, agglutination, large abnormal cells and platelet clumps, then use higher power for red-cell shape, white-cell maturation, inclusions and platelet morphology.
  • Schistocytes indicate mechanical fragmentation but are not synonymous with TTP; thrombocytopenia, haemolysis, renal, neurological and coagulation findings decide the thrombotic-microangiopathy or DIC pathway.
  • Spherocytes support extravascular red-cell membrane loss and occur in warm autoimmune haemolysis and hereditary spherocytosis. The direct antiglobulin test and family or transfusion history discriminate.
  • Target cells occur with haemoglobinopathy, liver disease, iron deficiency and hyposplenism; teardrops plus a leucoerythroblastic picture raise marrow fibrosis or infiltration but can have other causes.
  • Blasts require urgent expert classification. Abnormal promyelocytes with bleeding or coagulation disturbance raises acute promyelocytic leukaemia, for which specialist treatment is time critical.
  • Reactive lymphocytes can accompany viral infection, while a monotonous small-lymphocyte population suggests a clonal process. Flow cytometry answers lineage and clonality when indicated.
  • A negative or non-specific film does not exclude serious disease. Early haemolysis, marrow disease and infection may need serial counts, biochemical tests, cultures, flow or marrow assessment.

Key red flags

Microangiopathic pattern

Schistocytes with falling haemoglobin, thrombocytopenia, high LDH and low haptoglobin indicate fragmentation. Neurological, renal or cardiac involvement increases urgency for a thrombotic-microangiopathy pathway.

Acute leukaemia pattern

Circulating blasts, Auer rods or abnormal promyelocytes may accompany anaemia, thrombocytopenia and infection or bleeding. Prompt expert morphology, flow, genetics and coagulation assessment is required.

Blood-borne infection

Malaria parasites or other visible organisms in a compatible traveller can establish an urgent infectious diagnosis, but species, parasitaemia and repeat sampling follow specialist protocols.

Investigation priorities

01
Expert peripheral-film reviewFirst step

Confirm morphology, estimate abnormal-cell burden and issue time-critical alerts.

Management branches

FragmentationSeparate TMA from other fragmentation

Schistocytes accompany anaemia, thrombocytopenia or new renal, neurological, cardiac or bleeding features.

  1. Preferred first-line assessment is urgent repeat FBC, reticulocytes, LDH, bilirubin, haptoglobin, renal profile, urinalysis, coagulation, blood pressure and direct antiglobulin testing, with expert film confirmation.
  2. If TTP is plausible, send pre-plasma ADAMTS13 and escalate immediately to the regional TTP service; do not wait for a historical pentad or the activity result before specialist treatment decisions.
  3. Alternative causes include DIC, malignant hypertension, mechanical valves and severe burns; use coagulation, clinical context and organ pattern, escalating unresolved microangiopathic haemolysis to haematology.

Key medicines

Tretinoin (all-trans retinoic acid) for suspected APLStart 45 mg/m² per day by mouth in two divided doses immediately on morphological suspicion, under the acute-leukaemia protocol, without waiting for genetic confirmation.Specialist-only treatment is highly teratogenic and can cause differentiation syndrome, leukocytosis, hepatic toxicity and hyperlipidaemia. Monitor coagulation and fibrinogen closely; if differentiation syndrome is suspected, start protocol dexamethasone, commonly 10 mg intravenously every 12 hours, immediately.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BSH thrombotic microangiopathy guidelineSchistocyte-associated TTP recognition, ADAMTS13 sampling and urgent regional care.
  • BSH autoimmune haemolytic anaemia guidelineFilm, DAT and immune-haemolysis interpretation.
  • UKHSA malaria diagnosis and treatment guidanceUK diagnostic films, parasitaemia and urgent treatment pathway.
  • BSH acute promyelocytic leukaemia guidelineRecognition and emergency management of suspected APL.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom